SPRODIAMIDE HEXAHYDRATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H26N5O8.Dy.6H2O
Molecular Weight	686.998
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O.O.O.O.O.O.[Dy+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O

InChI

InChIKey=ZJMTWYFWQSWDGW-UHFFFAOYSA-K

InChI=1S/C16H29N5O8.Dy.6H2O/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;;;;;;;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);;6*1H2/q;+3;;;;;;/p-3

HIDE SMILES / InChI

Molecular Formula	Dy
Molecular Weight	162.5
Charge	3
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	H2O
Molecular Weight	18.0153
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C16H26N5O8
Molecular Weight	416.4063
Charge	-3
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9170037 | https://www.ncbi.nlm.nih.gov/pubmed/8123724 | https://www.ncbi.nlm.nih.gov/pubmed/9040868

Sprodiamide is a nonionic paramagnetic dysprosium chelate agent patented by Salutar, Inc.as diagnostic imaging contrast media. Compare with gadolinium-based agents Sprodiamide shows a stronger T2 effect and negligible T1 effect. This property makes Sprodiamide useful for blood volume imaging. In a preclinical model of reperfused ischemia of the rat intestine administration of Sprodiamide improved the contrast between the normal and ischemic intestine on T2-weighted images, and administration of both gadodiamide and Sprodiamide improved the contrast on T1- and T2-weighted images.

Originator

Approval Year

PubMed

Title	Date	PubMed
Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates.	1997 Jan	9040868

Patents

Sample Use Guides

In Vivo Use Guide

0.1, 0.2, and 0.3 mmol/kg, at rates of 2 ml/second and 5 ml/second

Route of Administration: Intravenous

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:24:20 GMT 2023` Edited by `admin` on `Fri Dec 15 16:24:20 GMT 2023`
Record UNII	1C1ZU7JLFX
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SPRODIAMIDE HEXAHYDRATE

Common Name

English

SPRODIAMIDE HYDRATE

Common Name

English

DYSPROSIUM, AQUA(5,8-BIS(CARBOXYMETHYL)-11-(2-(METHYLAMINO)-2-OXOETHYL)-3-OXO-2,5,8,11-TETRAAZATRIDECAN-13-OATO(3-)-N5,N8,N11,O3,O5,O8,O11,O13)-, HEXAHYDRATE, (TPS-9-13421'2'55'6)-

Systematic Name

English

Code System Code Type Description

PUBCHEM

72941682